Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-05 12:23 pm Sale |
2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-3,708,838 (Position Closed) |
Filing |
| 2023-02-14 12:12 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% |
936,776 (+33.79%) |
Filing |
| 2021-12-23 5:28 pm Purchase |
2021-12-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% |
2,772,062 (New Position) |
Filing |